While both agents struggled with the inherent GI burden typical of GLP-1RAs, efpeglenatides limitations were largely dose-related and within manageable expectations, whereas taspoglutides combination of severe immunogenicity and hypersensitivity reactions rendered it clinically unviable
The focus shifted to GLP-1, with Svetlana Mojsov identifying its insulin-stimulating fragment, GLP-1(7-37), in 1983
Multiple studies show that exercise can improve your heart health, bone health, reduce your risk of cancer and risk of type 2 diabetes, and boost your mood
Some individuals have no symptoms while some experience extreme discomfort and spotting
Freezing the pen can change the medicines chemical structure, making it less effective
Not what youve been told